Skip to main content

Table 1 Patient characteristics

From: Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases

Patient characteristics Patients who received peri-operative chemotherapy Patients who underwent surgery alone Total cohort
Number of patients 38 13 51
Number of pulmonary resections 56 16 72
Age median (range) 61.4 (41–78) 65 (49–78) 63 (41–78)
Male:female 23:15 7:6 30:21
Site of primary    
 Colon 20 7 27
 Rectum 18 6 24
Stage at diagnosis    
 Stage II 8 6 14
 Stage III 20 4 24
 Stage IV 11 3 14
 Site of metastases    
 Liver 2 3 5
 Lung 8 0 8
 Lung + Omentum 1 0 1
Adjuvant chemotherapy for primary CRC
Yes 24 7 31
 With neoadjuvant CRT 3 4 7
 With neoadjuvant chemo + CRT 3 0 3
 With Adjuvant RT 0 1 1
No 8 1 9
Site of first metastases    
 Lung only 29 10 39
 Lung + liver 2 0 2
 Liver only 5 3 8
 Peritoneum 1 0 1
 Nodal (para-aortic) 1 0 1
CEA pre-treatment*    
 Recorded 35 (49 resections) 10 (12 resections) 45 (61 resections)
 Not Recorded 3 (7 resections) 3 (4 resections) 6 (11 resections)
 >institutional ULN 7 (8 resections) 2 (2 resections) 9 (10 resections)
 Median CEA (range) 2 μg/dl (1–1094) 1.5 μg/dl (<1-10) 2 μg/dl (<1-1094)
  1. Numbers in table refer to number of patients unless otherwise specified.
  2. *either prior to neoadjuvant chemotherapy or prior to surgery if no neoadjuvant chemotherapy given.